9] Risk factors for
central retinal vein occlusion.
Late hyperbaric oxygen treatment of cilioretinal artery occlusion with nonischemic
central retinal vein occlusion secondary to high altitude.
Mustard gas is an etiology of nonischemic
central retinal vein occlusion.
Intravitreal triamcinolone acetonide treatment of macular edema associated with
central retinal vein occlusion.
Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to
central retinal vein occlusion.
Central retinal vein occlusion study group found beneficial effect of laser treatment on neovascularization but failed to produce visual improvement in macular edema.
Patients with glaucoma or
central retinal vein occlusion were demonstrated to be hyperinsulinemic compared to the control group [46].
Treatment of
central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.
For the great majority of the population, exercise reduces the risk of diabetes, hypertension, and
central retinal vein occlusion (5).
Objectives: To determine the efficacy and safety of intra-vitreal Avastin (Bevacizumab) in cases having
central retinal vein occlusion.
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder that has been associated with various systemic pathological conditions, although the exact cause is unknown.
Although a laser treatment of the retina called grid photocoagulation has shown a benefit in improving the vision of patients with blockages in smaller branches of the retinal vein, there is presently no effective therapy for vision loss associated with macular edema after
central retinal vein occlusion-blockage in the main portion of the retinal vein, at the optic nerve.
